Therefore, this study systematically analyzed the expression, gene regulatory network, prognostic value, and target prediction of BRD2, BRD3, and BRD4 in ACC patients, elucidated the association between BET family and ACC, and identified potential new targets for ACC therapy. This evidence concerns the gene DNER and adrenal cortex carcinoma.